We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.
Other uncategorised cookies are those that are being analysed and have not been classified into a category as yet.
This content has been developed by Galderma and is intended for Healthcare Professionals Only

Only Sculptra contains the unique PLLA-SCA™ made the “Sculptra way”, which works across the 3 layers of the skin.¹˒⁷˒⁸
It’s proven to stimulate the body’s own collagen and elastin.⁹˒¹⁰

Sculptra offers firm, radiant skin for a natural, rejuvenated appearance for at least 2 years.¹³⁻¹⁶

Progressive and sustained effect on Cellulite, with visible results after one month¹³˒²⁰
All rights reserved. All materials within this document are protected by copyright law and may not be reproduced, distributed, displayed or published without the prior, express written permission of Galderma. Sculptra, PLLA-SCA and Galderma are trademarks owned by Galderma Holding S.A. This material refers only to the product certified underRegulation (EU) 2017/745(MDR). Legacy versions of the product remain available. All features and claims apply solely to the MDR-certified version. For full product information and the Instructions for Use (IFU), visit:https://www.galderma.com/library.
Please refer to the instructions for use within the product packaging prior to use for full information on contraindications, adverse events and precautions.
Adverse events should be reported.
For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Galderma (UK) Ltd. Email: medinfo.uk@galderma.com Tel: +44 (0)300 3035674
UKI-SCU-2600071 DOP April 2026
*We provide Galderma (U.K.) Limited with certain information on who has purchased their products through this website for consumer service/support and safety purposes. A copy of Galderma’s Privacy Notice explaining how your data will be collected, used, and disclosed by Galderma can be found here.